LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation-Reference-Cited by-同舟云学术

LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation

Published:2016-02 Issue: Volume:245 Page:200-211
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Afonso Pauline,Auclair Martine,Boccara Franck,Vantyghem Marie-Christine,Katlama Christine,Capeau Jacqueline,Vigouroux Corinne,Caron-Debarle Martine

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference61 articles.

1. Nuclear lamins, diseases and aging;Mattout;Curr. Opin. Cell Biol.,2006

2. Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice;Fong;Proc. Natl. Acad. Sci. U. S. A.,2004

3. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition;Glynn;Hum. Mol. Genet.,2005

4. A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria;Fong;Science,2006

5. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome;Eriksson;Nature,2003

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipodystrophic Laminopathies: From Dunnigan Disease to Progeroid Syndromes;International Journal of Molecular Sciences;2024-08-28

2. Long COVID as a disease of accelerated biological aging: An opportunity to translate geroscience interventions;Ageing Research Reviews;2024-08

3. Navigating Lipodystrophy: Insights from Laminopathies and Beyond;International Journal of Molecular Sciences;2024-07-23

4. Dysfunction of STING Autophagy Degradation in Senescent Nucleus Pulposus Cells Accelerates Intervertebral Disc Degeneration;International Journal of Biological Sciences;2024

5. Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction;Cells;2023-11-07